Jean‐Jacques Sotto

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 899 citations · Full text

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Pierre Fenaux, Claude Chastang, Sylvie Chevret et al. · Blood · 1999 · 743 citations

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

Frédéric Garban, Michel Attal, Mauricette Michallet et al. · Blood · 2006 · 370 citations · Full text

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

Stéphane de Botton, Sylvie Chevret, Miguel Á. Sanz et al. · British Journal of Haematology · 2000 · 145 citations

Hematological Malignancy, Medicine, European Trial +15

Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Joël Plumas, Marie‐Christine Jacob, Laurence Chaperot et al. · Blood · 1998 · 117 citations